期刊文献+

艰难梭菌感染实验室诊断方法的研究进展 被引量:8

Progress of laboratory diagnostic methods of Clostridium difficile infection
原文传递
导出
摘要 艰难梭菌是一种专性厌氧革兰阳性芽孢杆菌,一般认为是环境和人类肠道中的正常菌群。长期应用抗生素、免疫抑制剂或化疗药物使耐药的艰难梭菌产毒株过度繁殖并释放毒素是导致艰难梭菌相关性腹泻(CDAD)的主要因素。CDAD的发病率在全球范围内不断上升,尤其是高产毒株在北美地区引起了医院内的暴发流行,引起了世界范围的关注。在此对艰难梭菌的致病机制和实验室诊断方法的研究进展进行阐述,为CDAD的早期诊断和治疗提供新思路。 Clostridium difficile is a gram-positive, anaerobic spore-forming bacillus commonly found in the environment and human gut. Excessive use of antibiotics, immunosuppressive agents and chemotherapy drugs may lead to overgrowth of the toxic strain of Clostridium dofieile with high resistance, which are supposed to be the major contributing factors leading to Clostridium difficile associated diarrhea(CDAD). The globally increasing incidence of CDAD, especially the outbreak of nosocomial infection caused by the hypervirulent strain in North America, arouse worldwide attention. For providing new ideas to the early diagnosis and treatment of CDAD, this review summarize the latest development on pathogenesis and rapid laboratory diagnosis of Clostridittm difficile.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2012年第8期692-696,共5页 Chinese Journal of Laboratory Medicine
基金 河北省科技厅基础条件平台建设项目(10966142D)
关键词 梭菌 难辨 小肠结肠炎 伪膜性 实验室技术和方法 Clostridium difficile Enterocolitis, pseudomembranous Laboratory techniques andprocedures
  • 相关文献

参考文献39

  • 1McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2005. Emerg Infect Dis, 2006, 12:409-415.
  • 2Kelly CP, LaMont JT. Clostridium difficile--more difficult than ever. N Engl J Med, 2008, 359:1932-1940.
  • 3Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-assoeiated diarrhea with high morbidity and mortality. N Engl J Med, 2005, 353:2442-2449.
  • 4Geric B, Rupnik M, Gerding DN, et al. Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital. J Med Microbiol, 2004, 53:887-894.
  • 5Rupnik M. How to detect Clostridium difficile variant strains in a routine laboratory. Clin Microbiol Infect, 2001, 7:417-420.
  • 6Kuehne SA, Cartman ST, Heap JT, et al. The role of toxin A and toxin B in Clostridium difftcile infection. Nature, 2010, 467:711-713.
  • 7Spigaglia P, Mastrantonio P. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production ( TcdC ) among Clostridium difficile clinical isolates. J Clin Microbiol, 2002, 40:3470-3475.
  • 8Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol,2009, 7:526-536.
  • 9Popoff MR, Rubin EJ, Gill DM, et al. Actin-specific ADP- fihosyltransferase produced by a Clostridium difficile strain. Infect Immun, 1988, 56:2299-2306.
  • 10Merz CS, Kramer C, Forman M, et al. Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin (s) from stool specimens. J Clin Microbiol, 1994, 32 : 1142-1147.

同被引文献116

  • 1王飞,贺蓓.难辨梭状芽孢杆菌相关性腹泻暴发流行的调查[J].中华医学杂志,2006,86(6):432-432. 被引量:9
  • 2KarasJA, Enoch DA, Aliyu SH, et al. A review of mortality due to Clostridium difficile infection[J].J Infect, 2010,61 (1) : 1-8.
  • 3Mullan N, Hughes KR, Mahida YR. Primary human colonic myofibroblasts are resistant to Clostridium difficile toxin A- ? induced, but not toxin B-induced , cell death[J]. Infect Imrnun , 2011,79(4):1623-1630.
  • 4Zilberberg MD, Shorr AF, Kollef MH, et al. Increase in Clostridium difficile-related hospitalizations among infants in the United States, 2000-2005[J]. Pediatr Infect DisJ, 2008,27 (12): 1111-1113.
  • 5Toltzis P,KimJ,Dul Mv et al. Presence of the epidemic North American Pulsed Field type 1 Clostridium difficile strain in hospitalized children[J].J Pediatr , 2009, 154( 4) :607-608.
  • 6Centers for Disease Control and Prevention (CDC). Surveillance for community-associated Clostridium difficile?Connecticut,2006[J]. MMWR Morb Mortal wu, Rep,2008, 57(13) :340-343.
  • 7Sandora TJ,Fung Mv Flaherty Kv et al. Epidemiology and risk factors for Clostridium difficile infection in children[J]. Pediatr Infect DisJ, 2011,30(7): 580-584.
  • 8Enoch DA, Butler MJ, Pai S, et al. Clostridium difficile in children: colonisation and disease[J].J Infect, 2011, 63 (2): 105-113.
  • 9Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonizationj]]. N EnglJ Med,2011,365(18):1693-1703.
  • 10Aslam S, Hamill RJ, Musher DM, et al. Treatment of Clostridium difficile-associated disease: old therapies and new strategies] I]. Lancet Infect Dis, 2005,5 (9) : 549-557.

引证文献8

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部